Avantor (AVTR) vs EyePoint (EYPT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Avantor (AVTR) has outperformed EyePoint (EYPT) over the past year, gaining 14.0% versus a loss of 74.9%. Over five years, AVTR leads with a -60.0% price change compared with -71.0% for EYPT. Avantor is the larger company by market cap ($10.27 billion vs $285.9 million), about 35.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVTR | EYPT |
|---|---|---|
| Share price | $15.19 | $3.41 |
| Market cap | $10.27B | $285.89M |
| 1-day change | -1.07% | +2.71% |
| YTD return | +33.94% | -81.83% |
| 1-year return | +13.96% | -74.94% |
| 5-year return | -59.97% | -70.98% |
| Forward P/E | 17.31 | — |
| EPS (TTM) | $-0.84 | $-3.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $6.55B | — |
| Revenue growth (YoY) | -3.41% | — |
| Net income (latest FY) | $-530.20M | — |
| Gross margin | 32.65% | — |
| Operating margin | -3.76% | — |
| Net margin | -8.09% | — |
| 52-week high | $16.38 | $19.11 |
| 52-week low | $7.27 | $3.05 |
| Distance from 52-week high | -7.27% | -82.16% |
| Analyst consensus | hold | none |
| Avg. price target upside | -2.67% | +659.85% |
| Average volume | 9.43M | 3.93M |
| Shares outstanding | 676.36M | 83.84M |
| Employees | 13,500 | 214 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Avantor is about 35.9 times larger than EyePoint by market value ($10.27B vs $285.89M).
- AVTR has outperformed EYPT by 88.9 percentage points over the past year.
About Avantor
AVTR stock →Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
Industrials · Biotechnology: Laboratory Analytical Instruments · 13,500 employees
About EyePoint
EYPT stock →EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
Industrials · Biotechnology: Laboratory Analytical Instruments · 214 employees
AVTR vs EYPT FAQ
Which is bigger, Avantor or EyePoint?
Avantor (AVTR) is larger, with a market capitalization of $10.27B compared with $285.89M for EyePoint (EYPT).
Which stock has performed better over the past year, AVTR or EYPT?
AVTR returned +13.96% over the past 12 months, compared with -74.94% for EYPT (price return, excluding dividends). Past performance does not predict future results.
Are Avantor and EyePoint in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.